Get startedLog in
    Picture of Matinas BioPharma Holdings logo

    MTNB — Matinas BioPharma Holdings News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapNeutral
    All News

    Brief: Matinas BioPharma Reports Second Quarter 2021 Financial Results And Operational Highlights

    Picture of Matinas BioPharma Holdings logoMatinas BioPharma Holdings
    10/08/2021 11:32
    Aug 10 (Reuters) - Matinas BioPharma Holdings Inc  MTNB.A :
    * MATINAS BIOPHARMA REPORTS SECOND QUARTER 2021 FINANCIAL
RESULTS
AND OPERATIONAL HIGHLIGHTS
    * Q2 LOSS PER SHARE $0.02
    * Q2 EARNINGS PER SHARE ESTIMATE $-0.03 -- REFINITIV IBES
DATA
    * BASED ON CURRENT PROJECTIONS, COMPANY BELIEVES THAT CASH
ON HAND
IS SUFFICIENT TO FUND OPERATIONS INTO 2024

Source text for Eikon:  ID:nGNX9X9F6y 
Further company coverage:  MTNB.A 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Matinas BioPharma Holdings

    See all news